Hero 2_COB21_WEREWOLF__3QtrRight_28226_943939.png

Putting control in your hands

Backed by 30 years of experience, legacy and innovation, WEREWOLF Technology continues the heritage of putting control in your hands. Seamlessly choose from three distinct COBLATION Technology modes (Low, Med, High) to get precisely the wand performance you need.

The WEREWOLF COBLATION system lets you control the mode from either the wand, foot pedal or touch screen interface.

Get MORE from your wands with the WEREWOLF COBLATION System.



Product Features

30 years of COBLATION technology​

Sports medicine resection was very different in the mid-1990s. Tools such as electrocautery performed a task at the time, but their reliance on heat-driven methods came with notable drawbacks in the form of thermal damage, a narrow margin of error around delicate anatomy, and adverse effects on patient healing. ​

A breakthrough concept of passing a radiofrequency current through saline emerged, allowing engineers to generate a low-temperature plasma field capable of disassociating tissue on a molecular level using energized ions rather than thermal destruction. ​

The resulting ‘controlled ablation’ (or COBLATION) entered the field of sports medicine in 1996 and offered surgeons a true alternative that redefined the standards for resection. ​

Continuing to evolve over three decades of research and innovation, including refined wand designs, improved delivery systems and expanded indications, COBLATION Technology continues to set the gold standard for resection.​

Medical education




Disclaimers

*Demonstrated in vitro.

**Demonstrated ex vivo; cell damage may vary depending on protocol used.

***AMBIENT SUPER MULTIVAC 50. Demonstrated in vitro.

****As demonstrated in vitro when tested at default settings; p<0.05.

Citations
  1. Amiel D, et al. Arthroscopy. 2004;20(5):503-510.
  2. ArthroCare 2014. Internal report. P/N 53303-01_A.
  3. Smith+Nephew 2020. Internal report. P/N 112090 Rev.A.
  4. ArthroCare Corporation 2015. Internal report. P/N 65200-01 Rev.A.
  5. Smith+Nephew 2019. Internal report. P/N 88079-01 Rev.C.

Title

Text